Back to top

Jazz Pharmaceuticals (JAZZ) Surges: Stock Moves 7.9% Higher

Read MoreHide Full Article

Jazz Pharmaceuticals plc (JAZZ - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $121.81 to $128.68 in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Jazz Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Jazz Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.

Investors interested in the Medical – Drugs industry may consider a better-ranked stock like Corbus Pharmaceuticals Holdings, Inc. (CRBP - Free Report) , which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
 
Is JAZZ going up? Or down? Predict to see what others think:Up or Down

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?

Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.

See Latest Stocks Today >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Corbus Pharmaceuticals Holdings, Inc. (CRBP) - free report >>

Jazz Pharmaceuticals PLC (JAZZ) - free report >>

More from Zacks Tale of the Tape

You May Like